This trial has been completed.

Condition vestibular diseases
Sponsor University of Zurich
Start date February 2015
End date November 2015
Trial size 48 participants
Trial identifier NCT02417545, KEK-ZH-2014-0509


The aim of this study is to assess the differences in gaze and gait during the stair and ramp negotiation (+transition to normal level walking) between healthy controls and vestibular patients (fallers and non-fallers).

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective

Primary Outcomes

time frame: 30 minutes

Secondary Outcomes

time frame: 30 minutes
Fall Calendar
time frame: one year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - All included patients are diagnosed with single or two-sided vestibular dysfunction. - Adult male and female participant's (≥18 years) - Signed informed consent after being informed Exclusion Criteria: - Benign paroxysmal positional vertigo - Acute pain - Walking disability (independent walking distance <10 meters) - Uncontrolled cardiovascular disease (e.g.: uncontrolled blood pressure) - Gait problems caused by Hip or knee endoprothesis - Weakness due to neurological problems - Known or suspected non-compliance - Contraindications on ethical grounds

Additional Information

Official title Gaze and Movement Behavior of Patients With Vestibular Dysfunction During Level Floor, Ramp, and Stair Walking
Principal investigator Jaap Swanenburg, PhD
Description For a better understanding of falls in patients with vestibular disorders it might be important to identify the challenging environmental that provoke functional deficits; e.g. stair or ramp negotiation. The three steps at the ground and at the top of stairs is the most common location for missteps and stair accidents. This is supported by the observation made in a 12-month prospective study were 32% of the falls happened during the last step going down stairs in vestibular patients. It remains open if patient's vestibular dysfunctions have a different gaze or gait behavior than healthy individuals.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by University of Zurich.